Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Pasireotide B2305 Study Group, ."'
Autor:
Pivonello, Rosario, Petersenn, Stephan, Newell-Price, John, Findling, James, Gu, Feng, Maldonado, Mario, Trovato, Andrew, Hughes, Gareth, Salgado, Luiz, Lacroix, André, Schopohl, Jochen, Biller, Beverly, Pasireotide B2305 Study Group, .
Publikováno v:
Clinical Endocrinology
Clinical Endocrinology, Wiley, 2014, 81 (3), pp.408-417. ⟨10.1111/cen.12431⟩
Clinical Endocrinology, Wiley, 2014, 81 (3), pp.408-417. ⟨10.1111/cen.12431⟩
International audience; ObjectiveSigns and symptoms of Cushing's disease are associated with high burden of illness. In this analysis, we evaluated the effect of pasireotide treatment on signs and symptoms in patients with Cushing's disease.DesignPha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1b79b45a940f1f845a922233e902d78
https://doi.org/10.1111/cen.12431
https://doi.org/10.1111/cen.12431
Autor:
Petersenn, S., Newell Price, J., Findling, J. W., Gu, F., Maldonado, M., Sen, K., Salgado, L. R., Colao, A., Biller, B. M. K., Pasireotide B2305 Study Group, Ghigo, Ezio
Publikováno v:
Clinical Endocrinology
Summary Objective Twenty-four-hour urinary free cortisol (UFC) sampling is commonly used to evaluate Cushing’s syndrome. Because there are few data on UFC variability in patients with active Cushing’s disease, we analysed baseline UFC in a large
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8a9dd85bb9098bff8ace85b0f4badad
https://www.ncbi.nlm.nih.gov/pubmed/23746264
https://www.ncbi.nlm.nih.gov/pubmed/23746264
Autor:
Colao A (AUTHOR), Petersenn S (AUTHOR), Newell-Price J (AUTHOR), Findling JW (AUTHOR), Gu F (AUTHOR), Maldonado M (AUTHOR), Schoenherr U (AUTHOR), Dipl-Biol (AUTHOR), Mills D (AUTHOR), Salgado LR (AUTHOR), Biller BM (AUTHOR), Pasireotide B2305 Study Group (CORPORATE AUTHOR)
Publikováno v:
New England Journal of Medicine. 3/8/2012, Vol. 366 Issue 10, p914-924. 11p.